logo-loader
CSE:SHRM

Champignon Brands Inc.

Receive alerts
Market:
CSE
Market Cap:
$70.54 m
Price
0.89 CAD
Change
3.49%
52 weeks high
2.40
52 weeks low
0.18

In brief

Champignon Brands Inc. (CSE: SHRM) is a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine. The Company specializes in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami's Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified.

Deep dive We explore the investor case for growth companies

Snapshot

As one of the first psychedelic companies to go public, the firm’s network of ketamine clinics complements its sharp focus on research and development